Microelectronic Medical Implants Market Growth & Trends

The global microelectronic medical implants market size is anticipated to reach USD 50.18 billion by 2030, according to a new report by Grand View Research, Inc., registering a 6.6% from 2024 to 2030. Increasing prevalence of cardiac disorders, epilepsy, and Parkinson’s disease, growing regulatory approvals for new devices and equipment, rising geriatric population, and introduction of new products are key factors driving market growth.

Regulatory authorities such as U.S. FDA have approved several new products and devices to be used by end users, most of which are equipped with new and innovative technologies that cater to varied consumer demands. These technologies also increase the ease of use of these products. For instance, in July 2017, Cochlear Ltd. introduced to the market a cochlear implant sound processor for iPhone. The U.S. FDA approved this innovation in June 2017.

Increasing prevalence of diseases such as epilepsy, cardiac disorders, and Parkinson’s disease have upped the sales of microelectronic electronic implants such as defibrillators, pacemakers, and neurostimulators. As per WHO, approximately 50 million people have epilepsy, globally, making it one of the most common neurological disorders. The condition can be treated using neurostimulators that prevent seizures.

Microelectronic Medical Implants Market Report Highlights

  • The pacemakers & defibrillators segment accounted for the largest market share of 34.3% in 2023 owing to increasing incidence of cardiac diseases and rising geriatric population.
  • The Radiofrequency (RF) technology segment accounted for the largest market share in 2023. RF technology is used in wireless implants to communicate with the circuitry outside the body.
  • North America microelectronic medical implants market dominated the market in 2023. The widespread use of advanced medical technology is attributing to the market growth in the region.